Cyclizine
Marezine (cyclizine) is a small molecule pharmaceutical. Cyclizine was first approved as Marezine on 1982-01-01. It is used to treat dizziness, nausea, vertigo, and vomiting in the USA. The pharmaceutical is active against histamine H1 receptor.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cyclizine lactate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MAREZINE | GSK | N-009495 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
dizziness | HP_0002321 | D004244 | R42 |
nausea | HP_0002018 | D009325 | R11.0 |
vertigo | — | D014717 | H81.39 |
vomiting | HP_0002013 | D014839 | R11.1 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | CYCLIZINE |
INN | cyclizine |
Description | Cyclizine is an N-alkylpiperazine in which one nitrogen of the piperazine ring is substituted by a methyl group, while the other is substituted by a diphenylmethyl group. It has a role as an antiemetic, a cholinergic antagonist, a central nervous system depressant, a local anaesthetic and a H1-receptor antagonist. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN1CCN(C(c2ccccc2)c2ccccc2)CC1 |
Identifiers
PDB | — |
CAS-ID | 82-92-8 |
RxCUI | 2977 |
ChEMBL ID | CHEMBL648 |
ChEBI ID | 3994 |
PubChem CID | 6726 |
DrugBank | DB01176 |
UNII ID | QRW9FCR9P2 (ChemIDplus, GSRS) |
Target
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 823 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
3,546 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more